• Je něco špatně v tomto záznamu ?

RGD-coated polymeric microbubbles promote ultrasound-mediated drug delivery in an inflamed endothelium-pericyte co-culture model of the blood-brain barrier

C. Hark, J. Chen, J. Blöck, EM. Buhl, H. Radermacher, R. Pola, M. Pechar, T. Etrych, Q. Peña, A. Rix, NI. Drude, F. Kiessling, T. Lammers, JN. May

. 2024 ; 14 (10) : 2629-2641. [pub] 20240318

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24018827

Drug delivery to central nervous pathologies is compromised by the blood-brain barrier (BBB). A clinically explored strategy to promote drug delivery across the BBB is sonopermeation, which relies on the combined use of ultrasound (US) and microbubbles (MB) to induce temporally and spatially controlled opening of the BBB. We developed an advanced in vitro BBB model to study the impact of sonopermeation on the delivery of the prototypic polymeric drug carrier pHPMA as a larger molecule and the small molecule antiviral drug ribavirin. This was done under standard and under inflammatory conditions, employing both untargeted and RGD peptide-coated MB. The BBB model is based on human cerebral capillary endothelial cells and human placental pericytes, which are co-cultivated in transwell inserts and which present with proper transendothelial electrical resistance (TEER). Sonopermeation induced a significant decrease in TEER values and facilitated the trans-BBB delivery of fluorescently labeled pHPMA (Atto488-pHPMA). To study drug delivery under inflamed endothelial conditions, which are typical for e.g. tumors, neurodegenerative diseases and CNS infections, tumor necrosis factor (TNF) was employed to induce inflammation in the BBB model. RGD-coated MB bound to and permeabilized the inflamed endothelium-pericyte co-culture model, and potently improved Atto488-pHPMA and ribavirin delivery. Taken together, our work combines in vitro BBB bioengineering with MB-mediated drug delivery enhancement, thereby providing a framework for future studies on optimization of US-mediated drug delivery to the brain.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24018827
003      
CZ-PrNML
005      
20241024111324.0
007      
ta
008      
241015s2024 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s13346-024-01561-6 $2 doi
035    __
$a (PubMed)38498080
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Hark, Christopher $u Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University, Aachen, Germany $1 https://orcid.org/000900064233588X
245    10
$a RGD-coated polymeric microbubbles promote ultrasound-mediated drug delivery in an inflamed endothelium-pericyte co-culture model of the blood-brain barrier / $c C. Hark, J. Chen, J. Blöck, EM. Buhl, H. Radermacher, R. Pola, M. Pechar, T. Etrych, Q. Peña, A. Rix, NI. Drude, F. Kiessling, T. Lammers, JN. May
520    9_
$a Drug delivery to central nervous pathologies is compromised by the blood-brain barrier (BBB). A clinically explored strategy to promote drug delivery across the BBB is sonopermeation, which relies on the combined use of ultrasound (US) and microbubbles (MB) to induce temporally and spatially controlled opening of the BBB. We developed an advanced in vitro BBB model to study the impact of sonopermeation on the delivery of the prototypic polymeric drug carrier pHPMA as a larger molecule and the small molecule antiviral drug ribavirin. This was done under standard and under inflammatory conditions, employing both untargeted and RGD peptide-coated MB. The BBB model is based on human cerebral capillary endothelial cells and human placental pericytes, which are co-cultivated in transwell inserts and which present with proper transendothelial electrical resistance (TEER). Sonopermeation induced a significant decrease in TEER values and facilitated the trans-BBB delivery of fluorescently labeled pHPMA (Atto488-pHPMA). To study drug delivery under inflamed endothelial conditions, which are typical for e.g. tumors, neurodegenerative diseases and CNS infections, tumor necrosis factor (TNF) was employed to induce inflammation in the BBB model. RGD-coated MB bound to and permeabilized the inflamed endothelium-pericyte co-culture model, and potently improved Atto488-pHPMA and ribavirin delivery. Taken together, our work combines in vitro BBB bioengineering with MB-mediated drug delivery enhancement, thereby providing a framework for future studies on optimization of US-mediated drug delivery to the brain.
650    12
$a hematoencefalická bariéra $x metabolismus $7 D001812
650    12
$a mikrobubliny $7 D045423
650    12
$a kokultivační techniky $7 D018920
650    _2
$a lidé $7 D006801
650    12
$a oligopeptidy $x chemie $x aplikace a dávkování $x farmakokinetika $7 D009842
650    12
$a pericyty $x metabolismus $x účinky léků $7 D020286
650    12
$a endoteliální buňky $x účinky léků $x metabolismus $7 D042783
650    _2
$a lékové transportní systémy $x metody $7 D016503
650    _2
$a ribavirin $x aplikace a dávkování $x chemie $x farmakokinetika $7 D012254
650    _2
$a ultrazvukové vlny $7 D000069453
650    _2
$a polymery $x chemie $x aplikace a dávkování $7 D011108
650    _2
$a antivirové látky $x aplikace a dávkování $x chemie $x farmakologie $x farmakokinetika $7 D000998
650    _2
$a zánět $x farmakoterapie $7 D007249
655    _2
$a časopisecké články $7 D016428
700    1_
$a Chen, Junlin $u Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University, Aachen, Germany
700    1_
$a Blöck, Julia $u Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University, Aachen, Germany
700    1_
$a Buhl, Eva Miriam $u Electron Microscopy Facility, Institute for Pathology, University Clinic RWTH Aachen, Aachen, Germany
700    1_
$a Radermacher, Harald $u Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University, Aachen, Germany
700    1_
$a Pola, Robert $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Pechar, Michal $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Etrych, Tomáš $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Peña, Quim $u Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University, Aachen, Germany $1 https://orcid.org/0000000164778127
700    1_
$a Rix, Anne $u Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University, Aachen, Germany $1 https://orcid.org/000000032624046X
700    1_
$a Drude, Natascha I $u QUEST Center for Responsible Research, Berlin Institute of Health at Charité, Berlin, Germany $1 https://orcid.org/0000000271532894
700    1_
$a Kiessling, Fabian $u Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University, Aachen, Germany $1 https://orcid.org/0000000273410399
700    1_
$a Lammers, Twan $u Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University, Aachen, Germany. tlammers@ukaachen.de $1 https://orcid.org/0000000210906805
700    1_
$a May, Jan-Niklas $u Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University, Aachen, Germany. jmay@ukaachen.de $1 https://orcid.org/0000000303276267
773    0_
$w MED00197253 $t Drug delivery and translational research $x 2190-3948 $g Roč. 14, č. 10 (2024), s. 2629-2641
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38498080 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20241015 $b ABA008
991    __
$a 20241024111318 $b ABA008
999    __
$a ok $b bmc $g 2201595 $s 1230800
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 14 $c 10 $d 2629-2641 $e 20240318 $i 2190-3948 $m Drug delivery and translational research $n Drug Deliv Transl Res $x MED00197253
LZP    __
$a Pubmed-20241015

Najít záznam

Citační ukazatele

Možnosti archivace